I think, Andrew, what we've seen actually, is the category, there's been quite a bit of innovation in the category, not just from us but from others. We view that as a good thing, overall, for the category because it means that these, not just ours, but brands across the category are good, strong brands, and that means the category is going to get more attention, more display, more merchandising space. So there has been some good innovation across the category, which we're very pleased about. I did mention that when you think about 3% or 4% top line, the longer Easter season certainly helps the category and helps us because Easter is a place where we have disproportionate share. So we think that, that will certainly help us. And then international continues to add. So if you look at 3% or 4% U.S. category growth and we've done very well in chocolate. Within the space, chocolate has actually been the best subsegment of the category, again, where we have disproportionate share. Those would be the things that I would say would give us some confidence around share. And then the International business outside of the U.S., we saw another solid year of growth in 2010, and we would expect the investments that we've made to start to pay out. Then Insights Driven Performance, if you think about what happens, our drug class-of-trade growth, as I mentioned in my remarks, was 9.4% in the fourth quarter. That's a big turnaround for us after having a number of quarters where we struggled, and so as we continue to work through IDP with our key customers in drug, we will expect to see some growth in that class-of-trade as well from a share standpoint. So it's a number of those initiatives, and then just good innovation. All of those building blocks, I think, make us feel pretty good about '11.